3 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
Follow Thymic epithelial tumor: new trials by email Literature Review of Thymic epithelial tumor trials Research Report on Thymic epithelial tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor Toripalimab + Chemotherapy - Thymic Epithelial Tumor | Phase 2 | Unknown | Shanghai Pulmonary Hospital, Shanghai, China | 15 | 2021-01-31 | 2023-04-04 |
| Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors rhGM-CSF，Peginterferon alfa-b2，radiation - Thymic Epithelial Tumor | Phase 2 | Unknown | Shanghai Cancer Hospital, China | 65 | 2020-12-01 | 2020-08-18 |
| neoadjuvant_thymic Epithelial Tumor pembrolizumab, Radiation - Thymic Epithelial Tumor | Phase 2 | Unknown | Samsung Medical Center | 40 | 2019-04-29 | 2021-03-22 |
Drug Therapy (1) · Radiation (1) · pembrolizumab (1) · toripalimab (1)
Samsung Medical Center (1) · Shanghai Cancer Hospital, China (1) · Shanghai Pulmonary Hospital, Shanghai, China (1)
China (2) · South Korea (1)